The Effects of Traditional Chinese Medicine-Associated Complementary and Alternative Medicine on Women with Polycystic Ovary Syndrome - PubMed (original) (raw)
Review
. 2021 Feb 26:2021:6619597.
doi: 10.1155/2021/6619597. eCollection 2021.
Affiliations
- PMID: 33727940
- PMCID: PMC7935578
- DOI: 10.1155/2021/6619597
Review
The Effects of Traditional Chinese Medicine-Associated Complementary and Alternative Medicine on Women with Polycystic Ovary Syndrome
Wenjuan Shen et al. Evid Based Complement Alternat Med. 2021.
Abstract
Polycystic ovary syndrome (PCOS) is a touchy clinical and public health problem worldwide, which adversely affects women's health and health-related comorbidities for lifetime, and represents a tremendous burden for both the family of the patient and for society. According to the diagnostic criteria used and the population studied, the prevalence rate of PCOS is between 6% and 21%. However, current conventional modern medicines for PCOS are only moderately effective at controlling the signs and symptoms, while they are not thoroughly able to prevent complications. Therefore, many patients have turned to complementary and alternative medical (CAM) treatments. CAM use is wide spread among patients with PCOS, and more than 70% of patients use CAM at one point during their diseases. The patients' primary motivations include dissatisfaction with available medications, perceive higher risk of drug side effects and crushing health burden and economic costs, desire for symptom relief, pursuit of shortening the course of disease, and the belief that CAM therapy is in accordance with the patients' values and beliefs. At present, several CAM methods have been used in women with PCOS, which has achieved obvious effects. However, biologically plausible mechanisms of the action of traditional Chinese medicine- (TCM-) associated CAM for PCOS have not been systematically reviewed. This review briefly summarizes the current progress of the impact of herbal medicine on the outcomes of PCOS and introduces the mechanisms.
Copyright © 2021 Wenjuan Shen et al.
Conflict of interest statement
The authors declare that there are no conflicts of interest in this work.
Similar articles
- A survey of the use of complementary medicine by a self-selected community group of Australian women with polycystic ovary syndrome.
Arentz S, Smith CA, Abbott JA, Bensoussan A. Arentz S, et al. BMC Complement Altern Med. 2014 Dec 6;14:472. doi: 10.1186/1472-6882-14-472. BMC Complement Altern Med. 2014. PMID: 25481654 Free PMC article. - The Complementary and Alternative Medicine for Polycystic Ovary Syndrome: A Review of Clinical Application and Mechanism.
Jia LY, Feng JX, Li JL, Liu FY, Xie LZ, Luo SJ, Han FJ. Jia LY, et al. Evid Based Complement Alternat Med. 2021 Feb 26;2021:5555315. doi: 10.1155/2021/5555315. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33727939 Free PMC article. Review. - The Treatment with Complementary and Alternative Traditional Chinese Medicine for Menstrual Disorders with Polycystic Ovary Syndrome.
Zhang Y, Guo X, Ma S, Ma H, Li H, Wang Y, Qin Z, Wu X, Han Y, Han Y. Zhang Y, et al. Evid Based Complement Alternat Med. 2021 May 17;2021:6678398. doi: 10.1155/2021/6678398. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34055020 Free PMC article. Review. - A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS).
Moini Jazani A, Nasimi Doost Azgomi H, Nasimi Doost Azgomi A, Nasimi Doost Azgomi R. Moini Jazani A, et al. Daru. 2019 Dec;27(2):863-877. doi: 10.1007/s40199-019-00312-0. Epub 2019 Nov 18. Daru. 2019. PMID: 31741280 Free PMC article. Review. - AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society (AES). Goodman NF, et al. Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC. Endocr Pract. 2015. PMID: 26509855
Cited by
- Food Cravings and Obesity in Women with Polycystic Ovary Syndrome: Pathophysiological and Therapeutic Considerations.
Stefanaki K, Karagiannakis DS, Peppa M, Vryonidou A, Kalantaridou S, Goulis DG, Psaltopoulou T, Paschou SA. Stefanaki K, et al. Nutrients. 2024 Apr 3;16(7):1049. doi: 10.3390/nu16071049. Nutrients. 2024. PMID: 38613082 Free PMC article. Review. - Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR, Li B, Zhang ZH, Wu HS, He XL, Dong YJ, Su J, Lv GY, Chen SH. Guan HR, et al. BMC Complement Med Ther. 2023 Dec 15;23(1):458. doi: 10.1186/s12906-023-04280-6. BMC Complement Med Ther. 2023. PMID: 38102584 Free PMC article. - Effects of natural products on polycystic ovary syndrome: From traditional medicine to modern drug discovery.
Jung W, Choi H, Kim J, Kim J, Kim W, Nurkolis F, Kim B. Jung W, et al. Heliyon. 2023 Oct 11;9(10):e20889. doi: 10.1016/j.heliyon.2023.e20889. eCollection 2023 Oct. Heliyon. 2023. PMID: 37867816 Free PMC article. - Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism.
Chen H, Deng C, Meng Z, Meng S. Chen H, et al. Front Endocrinol (Lausanne). 2023 May 16;14:956772. doi: 10.3389/fendo.2023.956772. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37260441 Free PMC article. Review. - Cangfudaotan decoction inhibits mitochondria-dependent apoptosis of granulosa cells in rats with polycystic ovarian syndrome.
Jiang XL, Tai H, Xiao XS, Zhang SY, Cui SC, Qi SB, Hu DD, Zhang LN, Kuang JS, Meng XS, Li SM. Jiang XL, et al. Front Endocrinol (Lausanne). 2022 Nov 9;13:962154. doi: 10.3389/fendo.2022.962154. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36465612 Free PMC article. Clinical Trial.
References
- Dumesic D. A., Oberfield S. E., Stener-Victorin E., Marshall J. C., Laven J. S., Legro R. S. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocrine Reviews. 2015;36(5):487–525. doi: 10.1210/er.2015-1018. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources